Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Sharma joined the Morepen Lab in 2004
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
The Convocation ceremony was organized for students skilled and certified in Ayush
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Subscribe To Our Newsletter & Stay Updated
